Analysts expect Polymet Mining Corp (TSE:POM) to report $0.00 EPS on June, 13. About 21,100 shares traded or 44.14% up from the average. Polymet Mining Corp (TSE:POM) has declined 13.33% since October 4, 2016 and is downtrending. It has underperformed by 24.92% the S&P500.
Cleveland BioLabs, Inc. is a biopharmaceutical company. The company has market cap of $39.98 million. The Firm is engaged in developing approaches to activate the immune system and address serious medical needs. It currently has negative earnings. The Company’s platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology.
PolyMet Mining Corp. is a development-stage company. The company has market cap of $278.10 million. The Firm is engaged in the exploration and development of natural resource properties. It currently has negative earnings. The Company’s sole mineral property is the NorthMet Project, which is located in St.
About 151,550 shares traded. Cleveland BioLabs, Inc. (NASDAQ:CBLI) has risen 112.66% since October 4, 2016 and is uptrending. It has outperformed by 101.07% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.